Search Results - Junlong Zhuang

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cover Image

    Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis by Zhongqing Zhang, Zhongqing Zhang, Tianlei Xie, Tianlei Xie, Shun Zhang, Shun Zhang, Haoli Yin, Haoli Yin, Xuyu Zhang, Xuyu Zhang, Siyuan Zhang, Wei Chen, Ding Yu, Xuefeng Qiu, Xuefeng Qiu, Wei Zhao, Hongqian Guo, Hongqian Guo, Junlong Zhuang, Junlong Zhuang

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Androgen deprivation therapy plus abiraterone or docetaxel as neoadjuvant therapy for very-high-risk prostate cancer: a pooled analysis of two phase II trials by Junlong Zhuang, Junlong Zhuang, Yuwen Wang, Yuwen Wang, Shun Zhang, Shun Zhang, Yao Fu, Haifeng Huang, Haifeng Huang, Xiaoyu Lyu, Xiaoyu Lyu, Shiwei Zhang, Shiwei Zhang, Giancarlo Marra, Linfeng Xu, Linfeng Xu, Xuefeng Qiu, Xuefeng Qiu, Hongqian Guo, Hongqian Guo, Hongqian Guo

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3 by Haoli Yin, Haixiang Qin, Lei Yang, Mengxia Chen, Yang Yang, Wenlong Zhang, Jiange Hao, Qun Lu, Jingyan Shi, Junlong Zhuang, Xuefeng Qiu, Hongqian Guo

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: